A new hat for an old enzyme: Waste management

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1761, Issue 11, 2006, Pages 1270-1279

  Brueseke, Taylor J ^a   Bell, John D ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Apoptosis; Binding; Enzyme kinetics; Fluorescence; Laurdan; Two photon microscopy

Indexed keywords

ISOENZYME; MEMBRANE LIPID; PHOSPHOLIPASE A2; PHOSPHOLIPID;

BINDING KINETICS; CELL DAMAGE; CELL INTERACTION; CELL KINETICS; CELL MEMBRANE; CELL MEMBRANE RESISTANCE; CELLULAR DISTRIBUTION; ENZYME ACTIVE SITE; ENZYME BINDING; ERYTHROCYTE; HUMAN; HYDROLYSIS; MEMBRANE BIOLOGY; MEMBRANE MODEL; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SEQUENCE HOMOLOGY; STRUCTURAL HOMOLOGY; STRUCTURE ANALYSIS; SURFACE PROPERTY;

ANIMALS; CELL DEATH; HUMANS; MEMBRANE LIPIDS; ORGAN SPECIFICITY; PHOSPHOLIPASES A; SUBSTRATE SPECIFICITY;

EID: 33751073672     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2006.05.012     Document Type: Review

References (96)

1. Triggiani M., Granata F., Giannattasio G., and Marone G. Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. J. Allergy Clin. Immunol. 116 (2005) 1000-1006
2. Schalkwijk C., Pfeilschifter J., Marki F., and van den B.H. Interleukin-1 beta, tumor necrosis factor and forskolin stimulate the synthesis and secretion of group II phospholipase A2 in rat mesangial cells. Biochem. Biophys. Res. Commun. 174 (1991) 268-275
3. Vlachojannis G.J., Scholz-Pedretti K., Fierlbeck W., Geiger H., Pfeilschifter J., and Kaszkin M. Enhanced expression of group IIA secreted phospholipase A2 by elevated glucose levels in cytokine-stimulated rat mesangial cells and in kidneys of diabetic rats. Clin. Nephrol. 63 (2005) 356-367
4. Peilot H., Rosengren B., Bondjers G., and Hurt-Camejo E. Interferon-gamma induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells. Involvement of cell differentiation, STAT-3 activation, and modulation by other cytokines. J. Biol. Chem. 275 (2000) 22895-22904
5. Kuwata H., Nonaka T., Murakami M., and Kudo I. Search of factors that intermediate cytokine-induced group IIA phospholipase A2 expression through the cytosolic phospholipase A2- and 12/15-lipoxygenase-dependent pathway. J. Biol. Chem. 280 (2005) 25830-25839
6. Wolbink G.J., Schalkwijk C., Baars J.W., Wagstaff J., van den B.H., and Hack C.E. Therapy with interleukin-2 induces the systemic release of phospholipase-A2. Cancer Immunol. Immunother. 41 (1995) 287-292
7. Sawada H., Murakami M., Enomoto A., Shimbara S., and Kudo I. Regulation of type V phospholipase A2 expression and function by proinflammatory stimuli. Eur. J. Biochem. 263 (1999) 826-835
8. Nakano T., Ohara O., Teraoka H., and Arita H. Glucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expression. J. Biol. Chem. 265 (1990) 12745-12748
9. Wu Y.Z., Medjane S., Chabot S., Kubrusly F.S., Raw I., Chignard M., and Touqui L. Surfactant protein-A and phosphatidylglycerol suppress type IIA phospholipase A2 synthesis via nuclear factor-kappaB. Am. J. Respir. Crit Care Med. 168 (2003) 692-699
10. Kudo I., Murakami M., Hara S., and Inoue K. Mammalian non-pancreatic phospholipases A2. Biochim. Biophys. Acta 1170 (1993) 217-231
11. Dennis E.A. Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269 (1994) 13057-13060
12. Cirino G. Multiple controls in inflammation. Extracellular and intracellular phospholipase A2, inducible and constitutive cyclooxygenase, and inducible nitric oxide synthase. Biochem. Pharmacol. 55 (1998) 105-111
13. Wei S., Ong W.Y., Thwin M.M., Fong C.W., Farooqui A.A., Gopalakrishnakone P., and Hong W. Group IIA secretory phospholipase A2 stimulates exocytosis and neurotransmitter release in pheochromocytoma-12 cells and cultured rat hippocampal neurons. Neuroscience 121 (2003) 891-898
14. Sun G.Y., Xu J., Jensen M.D., and Simonyi A. Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J. Lipid Res. 45 (2004) 205-213
15. Attalah H.L., Wu Y., Alaoui-El-Azher M., Thouron F., Koumanov K., Wolf C., Brochard L., Harf A., Delclaux C., and Touqui L. Induction of type-IIA secretory phospholipase A2 in animal models of acute lung injury. Eur. Respir. J. 21 (2003) 1040-1045
16. Beers S.A., Buckland A.G., Koduri R.S., Cho W., Gelb M.H., and Wilton D.C. The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. J. Biol. Chem. 277 (2002) 1788-1793
17. Buckland A.G., and Wilton D.C. The antibacterial properties of secreted phospholipases A(2). Biochim. Biophys. Acta 1488 (2000) 71-82
18. Buckland A.G., Heeley E.L., and Wilton D.C. Bacterial cell membrane hydrolysis by secreted phospholipases A(2): a major physiological role of human group IIa sPLA(2) involving both bacterial cell wall penetration and interfacial catalysis. Biochim. Biophys. Acta 1484 (2000) 195-206
19. N. Degousee, F. Ghomashchi, E. Stefanski, A. Singer, B.P. Smart, N. Borregaard, R. Reithmeier, T.F. Lindsay, C. Lichtenberger, W. Reinisch, G. Lambeau, J. Arm, J. Tischfield, M.H. Gelb, B.B. Rubin. Groups IV, V, and X phospholipases A2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis.
20. Dominiecki M.E., and Weiss J. Antibacterial action of extracellular mammalian group IIA phospholipase A2 against grossly clumped Staphylococcus aureus. Infect. Immun. 67 (1999) 2299-2305
21. Gronroos J.O., Laine V.J., and Nevalainen T.J. Bactericidal group IIA phospholipase A2 in serum of patients with bacterial infections. J. Infect. Dis. 185 (2002) 1767-1772
22. Gronroos J.O., Laine V.J., Janssen M.J., Egmond M.R., and Nevalainen T.J. Bactericidal properties of group IIA and group V phospholipases A2. J.Immunol. 166 (2001) 4029-4034
23. Koprivnjak T., Peschel A., Gelb M.H., Liang N.S., and Weiss J.P. Role of charge properties of bacterial envelope in bactericidal action of human Group IIA phospholipase A2 against Staphylococcus aureus. J. Biol. Chem. 277 (2002) 47636-47644
24. Qu X.D., and Lehrer R.I. Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect. Immun. 66 (1998) 2791-2797
25. Weinrauch Y., Elsbach P., Madsen L.M., Foreman A., and Weiss J. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J. Clin. Invest 97 (1996) 250-257
26. Weinrauch Y., Abad C., Liang N.S., Lowry S.F., and Weiss J. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2. J. Clin. Invest 102 (1998) 633-638
27. Lambeau G., and Lazdunski M. Receptors for a growing family of secreted phospholipases A2. Trends Pharmacol. Sci. 20 (1999) 162-170
28. Smith S.K., Farnbach A.R., Harris F.M., Hawes A.C., Jackson L.R., Judd A.M., Vest R.S., Sanchez S., and Bell J.D. Mechanisms by which intracellular calcium induces susceptibility to secretory phospholipase A2 in human erythrocytes. J. Biol. Chem. 276 (2001) 22732-22741
29. Wilson H.A., Waldrip J.B., Nielson K.H., Judd A.M., Han S.K., Cho W., Sims P.J., and Bell J.D. Mechanisms by which elevated intracellular calcium induces S49 cell membranes to become susceptible to the action of secretory phospholipase A2. J. Biol. Chem. 274 (1999) 11494-11504
30. Harris F.M., Smith S.K., and Bell J.D. Physical properties of erythrocyte ghosts that determine susceptibility to secretory phospholipase A2. J. Biol. Chem. 276 (2001) 22722-22731
31. Fox N., Song M., Schrementi J., Sharp J.D., White D.L., Snyder D.W., Hartley L.W., Carlson D.G., Bach N.J., Dillard R.D., Draheim S.E., Bobbitt J.L., Fisher L., and Mihelich E.D. Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors. Eur. J. Pharmacol. 308 (1996) 195-203
32. van den Bosch H., Aarsman A.J., van Schaik R.H., Schalkwijk C.G., Neijs F.W., and Sturk A. Structural and enzymological properties of cellular phospholipases A2. Biochem. Soc. Trans. 18 (1990) 781-785
33. Fourcade O., Simon M.F., Viode C., Rugani N., Leballe F., Ragab A., Fournie B., Sarda L., and Chap H. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80 (1995) 919-927
34. Murakami M., Kudo I., and Inoue K. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian 14-kDa group II phospholipase A2. FEBS Lett. 294 (1991) 247-251
35. Suga H., Murakami M., Kudo I., and Inoue K. Exogenous type-II phospholipase A2 stimulates prostaglandin synthesis in rat liver-derived BRL-3A cells in the presence of tumor necrosis factor alpha. J. Biochem. (Tokyo) 118 (1995) 939-945
36. Nielson K.H., Olsen C.A., Allred D.V., O'Neill K.L., Burton G.F., and Bell J.D. Susceptibility of S49 lymphoma cell membranes to hydrolysis by secretory phospholipase A(2) during early phase of apoptosis. Biochim. Biophys. Acta 1484 (2000) 163-174
37. Wilson H.A., Allred D.V., O'Neill K., and Bell J.D. Activities and interactions among phospholipases A2 during thapsigargin-induced S49 cell death. Apoptosis 5 (2000) 389-396
38. Elsbach P., and Weiss J. Phagocytosis of bacteria and phospholipid degradation. Biochim. Biophys. Acta 947 (1988) 29-52
39. Pruzanski W., de Beer F.C., de Beer M.C., Stefanski E., and Vadas P. Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. Biochem. J. 309 Pt 2 (1995) 461-464
40. Sweetman L.L., Zhang N.Y., Peterson H., Gopalakrishna R., and Sevanian A. Effect of linoleic acid hydroperoxide on endothelial cell calcium homeostasis and phospholipid hydrolysis. Arch. Biochem. Biophys. 323 (1995) 97-107
41. Atsumi G., Murakami M., Tajima M., Shimbara S., Hara N., and Kudo I. The perturbed membrane of cells undergoing apoptosis is susceptible to type II secretory phospholipase A2 to liberate arachidonic acid. Biochim. Biophys. Acta 1349 (1997) 43-54
42. R.S. Vest, R. Wallis, L.B. Jensen, A.C. Hawes, J. Callister, B. Brimhall, A.M. Judd, J.D. Bell. Use of steady state laurdan fluorescence to detect changes in liquid ordered phases in human erythrocyte membranes, J. Membr. Biol. (in press).
43. Bell J.D., and Biltonen R.L. The temporal sequence of events in the activation of phospholipase A2 by lipid vesicles. Studies with the monomeric enzyme from Agkistrodon piscivorus piscivorus. J. Biol. Chem. 264 (1989) 12194-12200
44. Bell J.D., Baker M.L., Bent E.D., Ashton R.W., Hemming D.J., and Hansen L.D. Effects of temperature and glycerides on the enhancement of Agkistrodon piscivorus piscivorus phospholipase A2 activity by lysolecithin and palmitic acid. Biochemistry 34 (1995) 11551-11560
45. Jain M.K., Yu B.Z., and Kozubek A. Binding of phospholipase A2 to zwitterionic bilayers is promoted by lateral segregation of anionic amphiphiles. Biochim. Biophys. Acta 980 (1989) 23-32
46. Burack W.R., Yuan Q., and Biltonen R.L. Role of lateral phase separation in the modulation of phospholipase A2 activity. Biochemistry 32 (1993) 583-589
47. Bell J.D., and Biltonen R.L. Molecular details of the activation of soluble phospholipase A2 on lipid bilayers. Comparison of computer simulations with experimental results. J. Biol. Chem. 267 (1992) 11046-11056
48. Jain M.K., and de Haas G.H. Activation of phospholipase A2 by freshly added lysophospholipids. Biochim. Biophys. Acta 736 (1983) 157-162
49. Jain M.K., and Jahagirdar D.V. Action of phospholipase A2 on bilayers. Effect of fatty acid and lysophospholipid additives on the kinetic parameters. Biochim. Biophys. Acta 814 (1985) 313-318
50. Bent E.D., and Bell J.D. Quantification of the interactions among fatty acid, lysophosphatidylcholine, calcium, dimyristoylphosphatidylcholine vesicles, and phospholipase A2. Biochim. Biophys. Acta 1254 (1995) 349-360
51. Jain M.K., Rogers J., Jahagirdar D.V., Marecek J.F., and Ramirez F. Kinetics of interfacial catalysis by phospholipase A2 in intravesicle scooting mode, and heterofusion of anionic and zwitterionic vesicles. Biochim. Biophys. Acta 860 (1986) 435-447
52. Menashe M., Romero G., Biltonen R.L., and Lichtenberg D. Hydrolysis of dipalmitoylphosphatidylcholine small unilamellar vesicles by porcine pancreatic phospholipase A2. J. Biol. Chem. 261 (1986) 5328-5333
53. Lichtenberg D., Romero G., Menashe M., and Biltonen R.L. Hydrolysis of dipalmitoylphosphatidylcholine large unilamellar vesicles by porcine pancreatic phospholipase A2. J. Biol. Chem. 261 (1986) 5334-5340
54. Gelb M.H., Jain M.K., Hanel A.M., and Berg O.G. Interfacial enzymology of glycerolipid hydrolases: lessons from secreted phospholipases A2. Annu. Rev. Biochem. 64 (1995) 653-688
55. Bell J.D., and Biltonen R.L. Thermodynamic and kinetic studies of the interaction of vesicular dipalmitoylphosphatidylcholine with Agkistrodon piscivorus piscivorus phospholipase A2. J. Biol. Chem. 264 (1989) 225-230
56. Yu B.Z., Berg O.G., and Jain M.K. The divalent cation is obligatory for the binding of ligands to the catalytic site of secreted phospholipase A2. Biochemistry 32 (1993) 6485-6492
57. Sheffield M.J., Baker B.L., Li D., Owen N.L., Baker M.L., and Bell J.D. Enhancement of Agkistrodon piscivorus piscivorus venom phospholipase A2 activity toward phosphatidylcholine vesicles by lysolecithin and palmitic acid: studies with fluorescent probes of membrane structure. Biochemistry 34 (1995) 7796-7806
58. Bell J.D., Burnside M., Owen J.A., Royall M.L., and Baker M.L. Relationships between bilayer structure and phospholipase A2 activity: interactions among temperature, diacylglycerol, lysolecithin, palmitic acid, and dipalmitoylphosphatidylcholine. Biochemistry 35 (1996) 4945-4955
59. Burack W.R., and Biltonen R.L. Lipid bilayer heterogeneities and modulation of phospholipase A2 activity. Chem. Phys. Lipids 73 (1994) 209-222
60. Burack W.R., Gadd M.E., and Biltonen R.L. Modulation of phospholipase A2: identification of an inactive membrane- bound state. Biochemistry 34 (1995) 14819-14828
61. Scott D.L., Mandel A.M., Sigler P.B., and Honig B. The electrostatic basis for the interfacial binding of secretory phospholipases A2. Biophys. J. 67 (1994) 493-504
62. Beers S.A., Buckland A.G., Giles N., Gelb M.H., and Wilton D.C. Effect of tryptophan insertions on the properties of the human group IIA phospholipase A2: mutagenesis produces an enzyme with characteristics similar to those of the human group V phospholipase A2. Biochemistry 42 (2003) 7326-7338
63. Tatulian S.A., Biltonen R.L., and Tamm L.K. Structural changes in a secretory phospholipase A2 induced by membrane binding: a clue to interfacial activation?. J. Mol. Biol. 268 (1997) 809-815
64. Tatulian S.A. Toward understanding interfacial activation of secretory phospholipase A2 (PLA2): membrane surface properties and membrane-induced structural changes in the enzyme contribute synergistically to PLA2 activation. Biophys. J. 80 (2001) 789-800
65. Tatulian S.A. Structural effects of covalent inhibition of phospholipase A(2) suggest allosteric coupling between membrane binding and catalytic sites. Biophys. J. 84 (2003) 1773-1783
66. Scott D.L., White S.P., Otwinowski Z., Yuan W., Gelb M.H., and Sigler P.B. Interfacial catalysis: the mechanism of phospholipase A2. Science 250 (1990) 1541-1546
67. Wu S.K., and Cho W. Use of polymerized mixed liposomes to study interactions of phospholipase A2 with membranes. Biochemistry 32 (1993) 13902-13908
68. Soltys C.E., Bian J., and Roberts M.F. Polymerizable phosphatidylcholines: importance of phospholipid motions for optimum phospholipase A2 and C activity. Biochemistry 32 (1993) 9545-9552
69. Henshaw J.B., Olsen C.A., Farnbach A.R., Nielson K.H., and Bell J.D. Definition of the specific roles of lysolecithin and palmitic acid in altering the susceptibility of dipalmitoylphosphatidylcholine bilayers to phospholipase A2. Biochemistry 37 (1998) 10709-10721
70. Honger T., Jorgensen K., Biltonen R.L., and Mouritsen O.G. Systematic relationship between phospholipase A2 activity and dynamic lipid bilayer microheterogeneity. Biochemistry 35 (1996) 9003-9006
71. Freire E., and Biltonen R.L. Thermodynamics of transfer ribonucleic acids: the effect of sodium on the thermal unfolding of yeast tRNAPhe. Biopolymers 17 (1978) 1257-1272
72. Jensen L.B., Burgess N.K., Gonda D.D., Spencer E., Wilson-Ashworth H.A., Driscoll E., Vu M.P., Fairbourn J.L., Judd A.M., and Bell J.D. Mechanisms governing the level of susceptibility of erythrocyte membranes to secretory phospholipase A2. Biophys. J. 88 (2005) 2692-2705
73. Balsinde J., and Dennis E.A. Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages. J. Biol. Chem. 271 (1996) 6758-6765
74. Reddy S.T., and Herschman H.R. Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells. J. Biol. Chem. 272 (1997) 3231-3237
75. Comfurius P., Senden J.M., Tilly R.H., Schroit A.J., Bevers E.M., and Zwaal R.F. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim. Biophys. Acta 1026 (1990) 153-160
76. Koumanov K., Wolf C., and Bereziat G. Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI. Biochem. J. 326 Pt 1 (1997) 227-233
77. Zwaal R.F., and Schroit A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89 (1997) 1121-1132
78. Zhou Q., Zhao J., Stout J.G., Luhm R.A., Wiedmer T., and Sims P.J. Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids. J. Biol. Chem. 272 (1997) 18240-18244
79. Best K., Ohran A., Hawes A., Hazlett T.L., Gratton E., Judd A.M., and Bell J.D. Relationship between erythrocyte membrane phase properties and susceptibility to secretory phospholipase A2. Biochemistry 41 (2002) 13982-13988
80. Parasassi T., De Stasio G., Ravagnan G., Rusch R.M., and Gratton E. Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence. Biophys. J. 60 (1991) 179-189
81. Vest R.S., Gonzales L.J., Permann S.A., Spencer E., Hansen L.D., Judd A.M., and Bell J.D. Divalent cations increase lipid order in erythrocytes and susceptibility to secretory phospholipase A2. Biophys. J. 86 (2004) 2251-2260
82. Sieber F. Merocyanine 540. Photochem. Photobiol. 46 (1987) 1035-1042
83. Stillwell W., Wassall S.R., Dumaual A.C., Ehringer W.D., Browning C.W., and Jenski L.J. Use of merocyanine (MC540) in quantifying lipid domains and packing in phospholipid vesicles and tumor cells. Biochim. Biophys. Acta 1146 (1993) 136-144
84. Williamson P., Mattocks K., and Schlegel R.A. Merocyanine 540, a fluorescent probe sensitive to lipid packing. Biochim. Biophys. Acta 732 (1983) 387-393
85. Yu H., and Hui S.W. Merocyanine 540 as a probe to monitor the molecular packing of phosphatidylcholine: a monolayer epifluorescence microscopy and spectroscopy study. Biochim. Biophys. Acta 1107 (1992) 245-254
86. Langner M., and Hui S.W. Merocyanine interaction with phosphatidylcholine bilayers. Biochim. Biophys. Acta 1149 (1993) 175-179
87. Bernik D.L., and Disalvo E.A. Gel state surface properties of phosphatidylcholine liposomes as measured with merocyanine 540. Biochim. Biophys. Acta 1146 (1993) 169-177
88. Lagerberg J.W., Kallen K.J., Haest C.W., VanSteveninck J., and Dubbelman T.M. Factors affecting the amount and the mode of merocyanine 540 binding to the membrane of human erythrocytes. A comparison with the binding to leukemia cells. Biochim. Biophys. Acta 1235 (1995) 428-436
89. Singer A.G., Ghomashchi F., Le Calvez C., Bollinger J., Bezzine S., Rouault M., Sadilek M., Lazdunski M., Lambeau G., and Gelb M.H. Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2. J. Biol. Chem. 277 (2002) 48535-48549
90. Murakami M., Hara N., Kudo I., and Inoue K. Triggering of degranulation in mast cells by exogenous type II phospholipase A2. J. Immunol. 151 (1993) 5675-5684
91. Balboa M.A., Balsinde J., Winstead M.V., Tischfield J.A., and Dennis E.A. Novel group V phospholipase A2 involved in arachidonic acid mobilization in murine P388D1 macrophages. J. Biol. Chem. 271 (1996) 32381-32384
92. Triggiani M., Granata F., Oriente A., De M., Gentile V.M., Calabrese C., Palumbo C., and Marone G. Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages. J. Immunol. 164 (2000) 4908-4915
93. Granata F., Petraroli A., Boilard E., Bezzine S., Bollinger J., Del Vecchio L., Gelb M.H., Lambeau G., Marone G., and Triggiani M. Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor. J. Immunol. 174 (2005) 464-474
94. Hack C.E., Wolbink G.J., Schalkwijk C., Speijer H., Hermens W.T., and van den B.H. A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. Immunol. Today 18 (1997) 111-115
95. Cummings B.S., McHowat J., and Schnellmann R.G. Phospholipase A(2)s in cell injury and death. J. Pharmacol. Exp. Ther. 294 (2000) 793-799
96. Taketo M.M., and Sonoshita M. Phospholipase A2 and apoptosis. Biochim. Biophys. Acta 1585 (2002) 72-76